CMEA VENTURES VI LP 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Mar 27, 2013
Insider Transaction Report
Form 4
CMEA VENTURES VI LP
10% Owner
Transactions
- Conversion
Common Stock
2013-03-25+23,639→ 36,790 total - Purchase
Common Stock
2013-03-25$7.00/sh+628,071$4,396,497→ 2,157,130 total - Conversion
Series A-2 Convertible Participating Preferred Stock
2013-03-25−2,662,059→ 0 total→ Common Stock (91,795 underlying) - Conversion
Series C Convertible Participating Preferred Stock
2013-03-25−685,531→ 0 total→ Common Stock (23,639 underlying) - Conversion
Common Stock
2013-03-25+1,693→ 1,693 total - Conversion
Common Stock
2013-03-25+91,795→ 162,171 total - Conversion
Common Stock
2013-03-25+9,250→ 13,151 total - Conversion
Series A-1 Convertible Participating Preferred Stock
2013-03-25−49,088→ 0 total→ Common Stock (1,693 underlying) - Conversion
Series A-1 Convertible Participating Preferred Stock
2013-03-25−2,040,912→ 0 total→ Common Stock (70,376 underlying) - Conversion
Common Stock
2013-03-25+70,376→ 70,376 total - Conversion
Common Stock
2013-03-25+2,208→ 3,901 total - Conversion
Common Stock
2013-03-25+384,613→ 546,784 total - Purchase
Common Stock
2013-03-25$7.00/sh+14,786$103,502→ 51,576 total - Conversion
Series B Convertible Participating Preferred Stock
2013-03-25−268,269→ 0 total→ Common Stock (9,250 underlying) - Conversion
Common Stock
2013-03-25+982,275→ 1,529,059 total - Conversion
Series A-2 Convertible Participating Preferred Stock
2013-03-25−64,027→ 0 total→ Common Stock (2,208 underlying) - Conversion
Series B Convertible Participating Preferred Stock
2013-03-25−11,153,776→ 0 total→ Common Stock (384,613 underlying) - Conversion
Series C Convertible Participating Preferred Stock
2013-03-25−28,485,997→ 0 total→ Common Stock (982,275 underlying)
Footnotes (4)
- [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
- [F2]Held by CMEA Ventures VI, GmbH & Co. KG. The general partner of CMEA Ventures VI, GmbH & Co. KG is CMEA Ventures VI Management, L.P. The general partners of CMEA Ventures VI Management, L.P. are Karl Handelsman, David Collier, Faysal Sohail, Thomas Baruch and James Watson. CMEA Ventures VI Management, L.P. and each of these individuals exercises shared voting and investment power over the shares held of record by CMEA Ventures VI, GmbH & Co. KG. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]Held by CMEA Ventures VI, L.P. The general partner of CMEA Ventures VI, L.P. is CMEA Ventures VI Management, L.P. The general partners of CMEA Ventures VI Management, L.P. are Karl Handelsman, David Collier, Faysal Sohail, Thomas Baruch and James Watson. CMEA Ventures VI Management, L.P. and each of these individuals exercises shared voting and investment power over the shares held of record by CMEA Ventures VI, L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F4]Not applicable.